Table.
Treatment Duration and Effects of Antifungals in Previous Reports of ABPM/MIB Caused by Schizophyllum commune.
| Age/Sex | Antifungals | Duration | Effect | Reference | ||||
|---|---|---|---|---|---|---|---|---|
| 54/F | ITCZ | 10 months | Ineffective | 18 | ||||
| 72/F | ITCZ and inhalation of amphotericin-B | 1 year | Effective | 19 | ||||
| 44/F | Inhalation of amphotericin-B plus ICS plus oral PSL | Unknown | Effective | 20 | ||||
| 51/F | Intravenous amphotericin-B | 1 month | Effective | 21 | ||||
| 51/F | ITCZ | 4 months | Effective | 22 | ||||
| 54/F | ITCZ | 3 months | Effective | 23 | ||||
| 75/F | ITCZ | 4 months | Effective | 24 | ||||
| 55/M | Oral PSL plus ITCZ | 134 days | Effective | 25 | ||||
| 64/F | ITCZ plus oral PSL | 3 months | Effective | 26 | ||||
| 63/F | Inhalation and intrabronchial administration of amphotericin-B | 2 months | Effective | 27 | ||||
| 53/F | Fluconazole Inhalation and intrabronchial administration of amphotericin-B |
Unknown Unknown |
Ineffective Effective |
27 | ||||
| 82/F | Oral PSL plus ITCZ plus inhalation of ICS | Unknown | Effective | 27 | ||||
| 53/F | ITCZ plus ICS and SM combination | Unknown | Effective | 28 | ||||
| 70/F | ITCZ | 3 months | Effective | 29 | ||||
| 61/F | Oral ITCZ and PSL | Unknown | Effective | 30 | ||||
| 59/F | VRCZ plus ICS | Unknown | Effective | 31 |
ABPM: allergic bronchopulmonary mycosis, MIB: mucoid impaction of the bronchi, S. commune: Schizophyllum commune, ITCZ: itraconazole, VRCZ: voriconazole, SM: salmeterol, PSL: prednisolone, ICS: inhaled corticosteroid